Sign In
Buy AVEO
$15.00
+0 (+0%)
At Close: Apr 18, 2023
AVEO Oncology Announces Restructuring of Existing Term Loan with Closing of New Tranched, $35 Million Debt Facility
12:00am, Monday, 10'th Aug 2020
AVEO Oncology (Nasdaq: AVEO) today announced the closing of a tranched, $35 million debt facility with Hercules Capital, Inc. (NYSE: HTGC) and its aff
Earnings Preview: AVEO Pharmaceuticals (AVEO) Q2 Earnings Expected to Decline
04:30pm, Thursday, 06'th Aug 2020
AVEO (AVEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AVEO Oncology Announces $2.8M Development Milestone Earned from Kyowa Kirin
08:05pm, Wednesday, 05'th Aug 2020
AVEO Oncology (Nasdaq: AVEO) today announced that it has earned a $2.8 million development milestone payment from partner Kyowa Kirin Co., Ltd. (Kyowa Kirin). The milestone relates to acceptance by th
Zacks: Analysts Anticipate AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Will Announce Quarterly Sales of $1.48 Million
01:56am, Wednesday, 05'th Aug 2020
Analysts expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) to announce sales of $1.48 million for the current fiscal quarter, according to Zacks. Two analysts have made estimates for AVEO Pharmaceutical
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Expected to Announce Earnings of -$0.51 Per Share
05:30am, Tuesday, 14'th Jul 2020
Equities analysts expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) to post earnings of ($0.51) per share for the current quarter, according to Zacks. Two analysts have provided estimates for AVEO Pharm
$1.48 Million in Sales Expected for AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) This Quarter
03:14am, Monday, 13'th Jul 2020
Equities research analysts expect AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) to post $1.48 million in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for A
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) Short Interest Update
03:36am, Tuesday, 07'th Jul 2020
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 2,010,000 shares, a
Two Sigma Investments LP Sells 89,040 Shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)
06:26am, Friday, 03'rd Jul 2020
Two Sigma Investments LP reduced its holdings in AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) by 86.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fu
New Strong Sell Stocks for July 1st
01:16pm, Wednesday, 01'st Jul 2020
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
AVEO Pharmaceuticals (NASDAQ:AVEO) Shares Up 7.3% Following Insider Buying Activity
01:20am, Wednesday, 24'th Jun 2020
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) shares shot up 7.3% during mid-day trading on Tuesday following insider buying activity. The company traded as high as $5.81 and last traded at $5.70, 1,759,00
AVEO Announces Closing of Public Offering of Common Stock and Partial Exercise of Option to Purchase Additional Shares
08:05pm, Friday, 19'th Jun 2020
AVEO Oncology (Nasdaq: AVEO) today announced the closing of its previously announced underwritten public offering of 9,725,000 shares of its common stock, which includes the partial exercise by the un
AVEO Announces Closing of Public Offering of Common Stock and Partial Exercise of Option to Purchase Additional Shares
12:00am, Friday, 19'th Jun 2020
AVEO Oncology (Nasdaq: AVEO) today announced the closing of its previously announced underwritten public offering of 9,725,000 shares of its common st
Best baby trikes for 2020
10:12pm, Wednesday, 17'th Jun 2020
Keep babies and smaller children secure and entertained on the go. We've rounded up top trike options for little ones, including bestsellers from smarTrike and TryBike
AVEO Announces Pricing of $44.6 Million Public Offering of Common Stock
02:38am, Wednesday, 17'th Jun 2020
AVEO Oncology (Nasdaq: AVEO) today announced that it has priced its previously announced underwritten public offering of 8,500,000 shares of its common stock at a price to the public of $5.25 per shar
AVEO Announces Pricing of $44.6 Million Public Offering of Common Stock
12:00am, Wednesday, 17'th Jun 2020
AVEO Oncology (Nasdaq: AVEO) today announced that it has priced its previously announced underwritten public offering of 8,500,000 shares of its commo
